{"id":54358,"date":"2023-03-01T04:03:21","date_gmt":"2023-03-01T03:03:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-one-mind-announces-inaugural-cohort-for-the-one-mind-accelerator-a-new-program-to-fast-track-breakthroughs-in-mental-health-through-startups\/"},"modified":"2023-03-01T04:03:21","modified_gmt":"2023-03-01T03:03:21","slug":"correcting-and-replacing-one-mind-announces-inaugural-cohort-for-the-one-mind-accelerator-a-new-program-to-fast-track-breakthroughs-in-mental-health-through-startups","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-one-mind-announces-inaugural-cohort-for-the-one-mind-accelerator-a-new-program-to-fast-track-breakthroughs-in-mental-health-through-startups\/","title":{"rendered":"CORRECTING and REPLACING One Mind\u2122 Announces Inaugural Cohort for the One Mind Accelerator, a New Program to Fast-Track Breakthroughs in Mental Health through Startups"},"content":{"rendered":"
\n

\nA cohort of eleven emerging companies developing innovative solutions for mental health conditions will receive $1 Million total in investment along with mentoring, training, and investor access<\/i>\n<\/p>\n

RUTHERFORD, Calif.–(BUSINESS WIRE)–First bullet point of the release should read: Ceretype<\/a><\/b> – an in-market, audit-cleared brain \u201cbiomarker engine\u201d \u2013 a novel fMRI platform incorporating optimal image acquisition and advanced analytics that de-risks and accelerates the development of psychiatric and neurological and therapies.\n<\/p>\n

<\/a><\/p>\n

\nThe updated release reads:\u00a0\n<\/p>\n

\nONE MIND\u2122 ANNOUNCES INAUGURAL COHORT FOR THE ONE MIND ACCELERATOR, A NEW PROGRAM TO FAST-TRACK<\/b> BREAKTHROUGHS IN MENTAL HEALTH THROUGH STARTUPS<\/b>\n<\/p>\n

\nA cohort of eleven emerging companies developing innovative solutions for mental health conditions will receive $1 Million total in investment along with mentoring, training, and investor access<\/i>\n<\/p>\n

\nOne Mind\u2122<\/a><\/b>, a leading mental health non-profit with a 28+ year track record of supporting psychiatric research, has announced the eleven companies making up the inaugural cohort for the One Mind Accelerator<\/a><\/b>. The intensive ten-week program, which launched on February 27, 2023, aims to help founders rapidly build and scale early-stage startups developing real-world solutions to improve the lives of people facing mental health conditions. Out of 105 applications received, eleven early-stage startups were selected to participate and will each receive a $100,000 investment.\n<\/p>\n

\nThe eleven emerging companies selected to participate in the One Mind Accelerator are:\n<\/p>\n